Search results
Results from the WOW.Com Content Network
On Oct. 10, Boston Scientific sent an urgent medical device advisory to all affected customers with recommendations. FDA classifies recall of Boston Scientific catheters as 'most serious' Skip to ...
An investigation showed that Boston's device, Obsidio Embolic, when used with a specific technique posed a higher risk of bowel ischemia during procedures to stop gastrointestinal (GI) bleeding ...
A drug-eluting stent (DES) is a small mesh tube that is placed in the arteries to keep them open in the treatment of vascular disease.The stent slowly releases a drug to block cell proliferation (a biological process of cell growth and division), thus preventing the arterial narrowing that can occur after stent implantation.
Covered stents carry the advantage of preventing tumours from growing into the stent, although they run the risk of increased migration after deployment. [6] A plastic self-expanding stent (Polyflex, Boston Scientific) has also been developed for similar applications. It confers an additional advantage as it is designed to be removable, and may ...
Kenneth Frank Binmoeller is a medical doctor and author of multiple scientific contributions [1] and over 300 publications, [2] [3] as well as the inventor of the lumen-apposing metal stent (LAMS) [4] [5] and AXIOS System. [6] [7] These are medical devices used to relieve blockages while creating a direct connection between two bodily ...
Shares of the medical device maker rose 1.5% in afternoon trading. The approval makes the device, branded Agent, the first drug-coated balloon catheter in the U.S. to treat coronary in-stent ...
The transfemoral approach requires the catheter and valve to be inserted via the femoral artery. Similar to coronary artery stenting procedures, this is accessed via a small incision in the groin, through which the delivery system is slowly fed along the artery to the correct position at the aortic valve.
Medical-device maker Boston Scientific yesterday released data from a clinical trial showing that its Promus Element drug-eluting stent showed advantages over Abbott's Xience V drug-eluting stent ...